Mid-East Companies: Crackdown on substituting epilepsy drugs...

To view this email as a webpage, click here     Monday November 18 2013     Middle East   Crackdown on substituting epilepsy drugs   New guidelines from the national medicines regulator will give drug companies producing some treatments for epilepsy less scope to compete in the UK                 Manage email    Forward this email   Feedback    Manage portfolio Subscribe to the FT Follow the FT   Unsubscribe | My Account | RSS | Privacy Policy | About Us | Help   © THE FINANCIAL TIMES LTD 2013 You have received this email because you have signed up from the NBE preference page. This email was sent by a company owned by Pearson plc, registered office at 80 Strand, London WC2R 0RL. Registered in England and Wales with company number 53723.